| For: | Hernández-Almonacid PG, Marín-Quintero X. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches. World J Gastroenterol 2026; 32(2): 111737 [PMID: 41551828 DOI: 10.3748/wjg.v32.i2.111737] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i2/111737.htm |
| Number | Citing Articles |
| 1 |
Brittany Bromfield, Jeremy Chimene-Weiss, Gregory Gheewalla, Theodore Feldman, Emilie K. Mitten, Piero Portincasa, Gyorgy Baffy. Prediction of trajectories and outcomes in early-stage metabolic dysfunction-associated steatotic liver disease: a narrative review. eClinicalMedicine 2026; 95 doi: 10.1016/j.eclinm.2026.103921
|
| 2 |
Shunqin Jin, Tao Zhou, Dachuan Jin, Jiahao Xie, Guoping Sheng, Hongzhi Li, Guangming Li, Chuan Qin, Peng Gao. Imaging-based fibrosis assessment and risk stratification in MASLD. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1880238
|
| 3 |
Yasser Fouad, Mohamed AbdAllah. Enhanced Liver Fibrosis (ELF): From Prediction to Precision in MASLD. Liver International 2026; 46(8) doi: 10.1111/liv.70810
|